Pregnant women presenting with a rash illness, or who have been in contact with rash illnesses should be managed as per: Guidance on the investigation, diagnosis and management of viral illness, or exposure to viral rash illness, in pregnancy (

Included in this guidance is the following (section 3.2.3):

“Neonates born to measles infected mothers Human normal immunoglobulin (HNIG) is recommended for neonates born to mothers who develop a measles rash 6 days before to 6 days after delivery. For neonates and infants exposed to measles, HNIG is recommended for up to and including 8 months of age. The dosage for infants is described in the National measles guidelines.”

Measles resources for health care professionals

Measles: guidance, data and analysis
The symptoms, diagnosis, management, surveillance and epidemiology of measles. Contains an excellent slide sets for maternity services and paediatrics - GOV.UK (

Local Health Protection Teams
The local Health Protection Team (details can be found at can provide urgent assistance, risk assessment and advice on post exposure prophylaxis.

Information for HCPs

RCPCH measles update webinar
In this webinar, Dr Elizabeth Whittaker, Professor Shamez Ladhani and Nalini Iyanger will provide an essential update on measles in children, ahead of an outbreak.

British Association of Perinatal Medicine (BAPM) is registered in England & Wales under charity number 1199712 at 5-11 Theobalds Road, London, WC1X 8SH.
Log in | Powered by White Fuse